Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

Also called NCT02004730

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
Registry
  • NCT NCT02004730
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02004730. Non-randomized; no masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears
Intervention (Device)
ABSORB implantation
Lead sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (class: other)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02004730
Content hash
c4fe2e459cbaff136e96599ad022a29961d301b8f77ed28e1432697d725068a3